Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Accumulated Expenses (2016 - 2017)

Bone Biologics has reported Accumulated Expenses over the past 3 years, most recently at $456000.0 for Q4 2017.

  • Quarterly Accumulated Expenses rose 994.39% to $456000.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $456000.0 through Dec 2017, up 994.39% year-over-year, with the annual reading at $456000.0 for FY2017, 994.39% up from the prior year.
  • Accumulated Expenses was $456000.0 for Q4 2017 at Bone Biologics, up from $191667.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $456000.0 in Q4 2017 and troughed at $41667.0 in Q4 2016.
  • The 3-year median for Accumulated Expenses is $138465.5 (2015), against an average of $164304.0.
  • Year-over-year, Accumulated Expenses plummeted 69.2% in 2016 and then soared 994.39% in 2017.
  • A 3-year view of Accumulated Expenses shows it stood at $135264.0 in 2015, then plummeted by 69.2% to $41667.0 in 2016, then soared by 994.39% to $456000.0 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Accumulated Expenses are $456000.0 (Q4 2017), $191667.0 (Q3 2017), and $141667.0 (Q2 2017).